bioRxivPhysiology
Kynurenine metabolism is altered in mdx mice: a potential muscle to brain connection
E. N. Copeland, K. C. Whitley, C. J. Watson, B. J. Baranowski, N. Kurgan, A. J. MacNeil, R. E. MacPherson, V. A. Fajardo, D. J. Allison
Abstract
Regular exercise can direct muscle kynurenine (KYN) metabolism toward the neuroprotective branch of the kynurenine pathway thereby limiting the accumulation of neurotoxic metabolites in the brain and contributing to mental resilience. While the effect of regular exercise has been studied, the effect of muscle disease on KYN metabolism has not yet been investigated. Previous work has highlighted anxiety-like behaviors in approximately 25% of patients with DMD, possibly due to altered KYN metabolism. Here, we characterized KYN metabolism in mdx mouse models of Duchenne muscular dystrophy (DMD). Young (8-10 week old) DBA/2J (D2) mdx mice, but not age-matched C57BL/10 (C57) mdx mice, had lower levels of circulating KYNA and KYNA:KYN ratio compared with their respective wild-type (WT) controls. Moreover, only D2 mdx mice displayed signs of anxiety-like behaviour, spending more time in the corners of their cages during a novel object recognition test when compared with WT. Along with this, we found that muscles from D2 mdx mice had less peroxisome proliferator-activated receptor-gamma coactivator 1-alpha and kynurenine amino transferase-1 enzyme content as well as elevated expression of inflammatory cytokines compared with WT muscles. Thus, our pilot work shows that KYN metabolism is altered in D2 mdx mice, with a potential contribution from altered muscle health.
- organism: mouse
- assay: metabolomics
- research focus: host-pathogen & immune response
- research focus: cell signaling & trafficking
- research focus: development & morphogenesis
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A motor axonopathy in a mouse model of Duchenne Muscular Dystrophy
Justin S. Dhindsa, Angela L. McCall, … Mai K. ElMallah·Scientific ReportsPeer-reviewed·Jun 2, 2020
- Desmin is a modifier of dystrophic muscle features in Mdx mice
A. Ferry, J. Messeant, … O. Agbulut·bioRxiv·Aug 23, 2019
- Parkin overexpression attenuates muscle atrophy and improves mitochondrial bioenergetics but fails to improve key histological features in a mouse model of Duchenne Muscular Dystrophy
Olivier Reynaud, Marie‐Belle Ayoub, … Gilles Gouspillou·bioRxiv·Jun 13, 2025
- Regimen-dependent glucocorticoid effects improve muscle performance without altering CNS physiology in mdx mice
Gretel S. Major, Jiayi Chen, … Angus Lindsay·The Journal of PhysiologyPeer-reviewed·May 28, 2026
- Inhibition of Mitochondrial Fission Protein Drp1 Ameliorates Myopathy in the D2-mdx Model of Duchenne Muscular Dystrophy
H. Grace Rosen, NICOLAS J. A. BERGER, … Kai Zou·bioRxiv·Dec 26, 2024
- Dimethyl fumarate modulates the Duchenne muscular dystrophy disease program following short-term treatment in mdx mice
C. A. Timpani, S. Kourakis, … E. Rybalka·bioRxiv·Sep 15, 2022